 |
| AUGUST
14, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Russ Lebovitz, CEO and Co-Founder, Amprion
Diagnostics |
| In
this Q&A, Lebovitz reflects on the
origin of the company, what sets its
platform apart, the milestones that matter
most, and the regulatory headwinds that
challenge the entire life sciences field.
He also shares a philosophy of leadership
grounded on an unwavering focus on
patients. More |
|
|
 |
Our
Newest Location: Mispro San
Diego!
Reserve
your space today in our Sorrento
Mesa
Contract Vivarium |
|
Learn More
→ |
|
|
- Fate
Therapeutics: Initiates Potentially
Registrational RECLAIM-LN Clinical Trial of
FT819 for the Treatment of Lupus Nephritis More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Aethlon Medical: Q1 Fiscal 2027 Results and
Progress on Hemopurifier Program More
- Arisan
Therapeutics: Selected for NIAID Contract
Award to Develop a Therapeutic Small
Molecule Viral Entry Inhibitor as a Medical
Countermeasure for Filovirus Infection More
- ARS Pharmaceuticals: Outlines Strategic
Priorities, Including a Focused Commercial
Strategy, and Reports Second Quarter 2026
Financial Results More
- Atrium Therapeutics: Earns $15 Million
Milestone Payment From Bristol Myers Squibb
Under Global Cardiovascular Collaboration More
- Atrium Therapeutics: Second Quarter 2026
Financial Results More
- Calidi Biotherapeutics: Second Quarter 2026
Financial Results and Recent Business
Highlights More
- Capricor Therapeutics: Second Quarter 2026
Financial Results and Provides Corporate
Update More
More*
- CV Sciences: Second Quarter-End 2026
Financial Results More
- Daré Bioscience: Second Quarter 2026 Results
and Highlights Commercial Inflection as
Multi-Product Women's Health Strategy Advances
More
- Ensysce Biosciences: Second Quarter 2026
Financial Results and Recent Business
Highlights More
- Equillium: Second Quarter 2026 Financial
Results and Recent Corporate Highlights More
- Fate Therapeutics: Second Quarter 2026
Financial Results and Business Updates More
- Gossamer Bio: Second Quarter 2026 Financial
Results and Provides Business Update More
- Inhibrx: Second Quarter 2026 Financial
Results More
- Khartis Therapeutics: Emerges From
Stealth With $95 Million in Funding to
Advance Oral Small Molecule Immunology
Pipeline More
More
- LSN: Hot Investor Mandate (Updated 8/11) More
- Zentalis Pharmaceuticals: Pricing of
Underwritten Public Offering More
|
|
- Big4Bio CEO Weekly Q&A: Russ
Lebovitz, CEO and Co-Founder, Amprion
Diagnostics More
- BioPharmGuy News: Floating Head, Viral
Freakout, Gene Therapy & Kalshi vs. Kids,
Shady Peptides More
- Biotech & Pharma Updates | August 13,
2026 More
- More on Neurocrine Standing by Blockbuster
Hopeful Vykat XR As Prader-Willi Docs Raise
Potential Safety Flags More
- Polsinelli: Supporting Life Sciences
From Formation to Exit More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- ICYMI: ADARx Pharmaceuticals Expands
Leadership Team With Board and Executive
Appointments More
- ICYMI: Erasca Strengthens R&D Leadership
With Appointment of Internationally Recognized
Medical Oncologist Charles S. Fuchs, M.D.,
M.P.H., as President of R&D More
- ICYMI: 2026 Q2 Job Market Report - Job
Postings Keep Rising as Fewer Companies Cut
Employees More
- OPPORTUNITY: Head of Marketing &
Communications, Remote More
- OPPORTUNITY: President, Specialty Laboratory
Services, PA More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- Pace: Appoints Andy Fenny
as President of Pace Life Sciences to Drive
Strategic Growth More
- Slone Partners: Names Sona Stroud and Kim
Wilson as Senior Partners More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
